1 Month Weight Loss Course (TIRZ)

Product Description – TIRZ (Tirzepatide)

Experience the next generation of metabolic support with TIRZ, a groundbreaking injectable therapy designed to assist with blood sugar control and weight management in adults with type 2 diabetes. Powered by the dual-action mechanism of tirzepatide, TIRZ targets both GLP-1 and GIP receptors—key hormones involved in glucose regulation and appetite control.

Key Benefits:

• Helps improve blood glucose levels in adults with type 2 diabetes
• Supports significant and sustained weight reduction when used alongside diet and exercise
• Once-weekly dosing for convenient, long-lasting action
• Dual receptor agonist for enhanced efficacy compared to older GLP-1 treatments

TIRZ is typically prescribed as part of a comprehensive care plan, which includes dietary guidance, physical activity, and regular medical supervision. It is administered via subcutaneous injection, with dosage adjustments tailored to individual response and tolerance.

Note: TIRZ is not approved for use in people with type 1 diabetes or for weight loss in individuals without diabetes. Always consult your healthcare provider to determine if TIRZ is appropriate for your treatment plan.